GCR 100 - 17th Edition

Analysis Group

08 March 2017

• A new entrant to this year’s Economics 21

• Boasts by far the largest amount of antitrust litigation advisory work in 2016, with its experts involved in 86 separate cases.

• The firm’s 2016 track record includes successful advisory work in major mergers and cartel class actions, advising both defendants and government plaintiffs in court.

Global heads

Martha Samuelson
Home jurisdiction US
Total size of firm 523
Competition economists 176
% of firm specialised 34%
Who’s Who Legal: Competition nominees 6
Group one N/A
Group two N/A
Group three N/A
Group four N/A
Lateral hires 1
Departures 2
Internal promotions 2

Analysis Group enters our Economics 21 list for the first time this year, and the firm’s inclusion is well deserved. The group’s numbers put it firmly in the top five of the categories we examine – including the third-most in-depth merger investigations of any group we poll (14), the fifth-most cases in which their clients were under government investigation (14) and by far the largest number of antitrust litigations (86). The 176 antitrust specialists at Analysis Group – the second-most in the Economics 21 – split their time between the various competition law disciplines. The total picture is a firm that is capable of handling almost any matter, staffing it with a team of talent and, in many cases, winning in court or before the agencies. The firm is indeed in the discussion of the best competition economics consultancy in the world.

The firm’s list of successful matters begins with its work for the US Department of Justice in its challenge of the Anthem/Cigna health insurance merger, which the DOJ successfully blocked in February, after the GCR 100 went to press. Analysis Group’s affiliate David Dranove, a professor at Northwestern University, testified multiple times in court on market definition, medical costs, competitive effects and barriers to entry, helping to convince the court that the deal would indeed harm competition. Bruce Deal, a managing principal at the firm, assisted a group of Chinese solar panel defendants in fending off predatory pricing claims in the Solyndra litigation, eventually securing a favourable settlement in the matter. The firm helped to prepare economic evidence for GlaxoSmithKline in the Wellbutrin pay-for-delay litigation, and it advised Toshiba and Mitsubishi Electric in the CRT class action, among other cases.

Previous Chapter:Alixpartners

Next Chapter:Bates White Economic Consulting